Literature DB >> 28586767

Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal.

William R Clark1, Martine Leblanc, Zaccaria Ricci, Claudio Ronco.   

Abstract

BACKGROUND/AIMS: Delivered dialysis therapy is routinely measured in the management of patients with end-stage renal disease; yet, the quantification of renal replacement prescription and delivery in acute kidney injury (AKI) is less established. While continuous renal replacement therapy (CRRT) is widely understood to have greater solute clearance capabilities relative to intermittent therapies, neither urea nor any other solute is specifically employed for CRRT dose assessments in clinical practice at present. Instead, the normalized effluent rate is the gold standard for CRRT dosing, although this parameter does not provide an accurate estimation of actual solute clearance for different modalities.
METHODS: Because this situation has created confusion among clinicians, we reappraise dose prescription and delivery for CRRT.
RESULTS: A critical review of RRT quantification in AKI is provided.
CONCLUSION: We propose an adaptation of a maintenance dialysis parameter (standard Kt/V) as a benchmark to supplement effluent-based dosing of CRRT. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=475457.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Clearance; Continuous renal replacement therapy; Critical care; Hemodialysis; Solute kinetics; Standard Kt/V; Urea

Mesh:

Substances:

Year:  2017        PMID: 28586767     DOI: 10.1159/000475457

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

1.  The 10 false beliefs in adult critical care nephrology.

Authors:  Zaccaria Ricci; Stefano Romagnoli; Claudio Ronco
Journal:  Intensive Care Med       Date:  2017-12-01       Impact factor: 17.440

Review 2.  Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Yasushi Tsujimoto; Sho Miki; Hiroki Shimada; Hiraku Tsujimoto; Hideto Yasuda; Yuki Kataoka; Tomoko Fujii
Journal:  Cochrane Database Syst Rev       Date:  2021-09-14

Review 3.  Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.

Authors:  Enzo Vásquez Jiménez; Samaya J Anumudu; Javier A Neyra
Journal:  Nephron       Date:  2021-02-04       Impact factor: 2.847

Review 4.  The future of critical care: renal support in 2027.

Authors:  William R Clark; Mauro Neri; Francesco Garzotto; Zaccaria Ricci; Stuart L Goldstein; Xiaoqiang Ding; Jiarui Xu; Claudio Ronco
Journal:  Crit Care       Date:  2017-04-11       Impact factor: 9.097

Review 5.  Methods for dose quantification in continuous renal replacement therapy: Toward a more precise approach.

Authors:  Gianluca Villa; Sergio Fabbri; Sara Samoni; Matteo Cecchi; Antonio Fioccola; Caterina Scirè-Calabrisotto; Gaia Mari; Diego Pomarè Montin; Stefano Romagnoli
Journal:  Artif Organs       Date:  2021-08-18       Impact factor: 3.094

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.